Group I metabotropic glutamate receptors: implications for brain diseases.
about
Mutations in the cholesterol transporter gene ABCA5 are associated with excessive hair overgrowthPositive allosteric modulators of metabotropic glutamate 1 receptor: characterization, mechanism of action, and binding siteBlockade of mGluR1 receptor results in analgesia and disruption of motor and cognitive performances: effects of A-841720, a novel non-competitive mGluR1 receptor antagonistDisruption of diacylglycerol kinase delta (DGKD) associated with seizures in humans and miceComputational methods in drug discoveryPresynaptic Release-Regulating mGlu1 Receptors in Central Nervous SystemUnderstanding how the brain perceives alcohol: neurobiological basis of ethanol discriminationTask-dependent role for dorsal striatum metabotropic glutamate receptors in memoryHippocampal Gαq/₁₁ but not Gαo-coupled receptors are altered in aging.A guide to the metabolic pathways and function of metabolites observed in human brain 1H magnetic resonance spectra.The mGluR5 antagonist MPEP selectively inhibits the onset and maintenance of ethanol self-administration in C57BL/6J mice.Tetrahydronaphthyridine and dihydronaphthyridinone ethers as positive allosteric modulators of the metabotropic glutamate receptor 5 (mGlu₅).Pharmacological and anatomical evidence for an interaction between mGluR5- and GABA(A) alpha1-containing receptors in the discriminative stimulus effects of ethanol.Regulation of cyclin-dependent kinase 5 and casein kinase 1 by metabotropic glutamate receptors.Fragile X mental retardation protein in plasticity and disease.Homer1a signaling in the amygdala counteracts pain-related synaptic plasticity, mGluR1 function and pain behaviors.Diacylglycerol kinase epsilon regulates seizure susceptibility and long-term potentiation through arachidonoyl- inositol lipid signaling.TREK-1, a K+ channel involved in neuroprotection and general anesthesia.Effect of latent iron deficiency on GABA and glutamate neuroreceptors in rat brain.Mechanisms underlying excitatory effects of group I metabotropic glutamate receptors via inhibition of 2P domain K+ channels[carbonyl-11C]4-Fluoro-N-methyl-N-(4-(6-(methylamino)pyrimidin-4-yl)thiazol-2-yl)benzamide ([11C]FIMX) is an effective radioligand for PET imaging of metabotropic glutamate receptor 1 (mGluR1) in monkey brain.Agonists and antagonists of metabotropic glutamate receptors: anticonvulsants and antiepileptogenic agents?Effects of mGlu1-receptor blockade on ethanol self-administration in inbred alcohol-preferring rats.Are compounds acting at metabotropic glutamate receptors the answer to treating depression?Kinetic analysis of the metabotropic glutamate subtype 5 tracer [(18)F]FPEB in bolus and bolus-plus-constant-infusion studies in humansRegulation of motivation to self-administer ethanol by mGluR5 in alcohol-preferring (P) rats.Is there hope for chronic pain and headache?Long-term potentiation of synaptic transmission in the adult mouse insular cortex: multielectrode array recordings.The Emerging Role of Metabotropic Glutamate Receptors in the Pathophysiology of Chronic Stress-Related DisordersG-protein-coupled receptors and melanomaInflammatory pain: the cellular basis of heat hyperalgesia.Silicon Wafer-Based Platinum Microelectrode Array Biosensor for Near Real-Time Measurement of Glutamate in Vivo.Hypoxia-ischemia and retinal ganglion cell damage.Synthesis and evaluation in monkey of [(18)F]4-fluoro-N-methyl-N-(4-(6-(methylamino)pyrimidin-4-yl)thiazol-2-yl)benzamide ([(18)F]FIMX): a promising radioligand for PET imaging of brain metabotropic glutamate receptor 1 (mGluR1)Noninvasive quantification of metabotropic glutamate receptor type 1 with [¹¹C]ITDM: a small-animal PET study.PET brain kinetics studies of (11)C-ITMM and (11)C-ITDM,radioprobes for metabotropic glutamate receptor type 1, in a nonhuman primate.Allosteric modulation of metabotropic glutamate receptors: structural insights and therapeutic potential.Dynamic action of neurometals at the synapse.NMDARs in neurological diseases: a potential therapeutic target.Metabotropic glutamate receptor 5 as a potential therapeutic target in Huntington's disease.
P2860
Q21144873-280E7290-0392-4F14-A76F-5F57577B80A9Q24555099-DF6E917F-667A-491F-8148-361FC3DC28A4Q24564987-BEE12B1F-5C9A-4D54-BFE7-2B46FE82BF30Q24682949-8774C2E1-1B97-4CA9-B929-59BB2EEB33F9Q26997089-4C4940EB-D095-4764-8CEC-BC81006A91D9Q28073858-73A6384D-5DFC-4B62-AE0E-8D7CDB190576Q28294104-E8191D00-7C63-4345-8FD5-787E8C6CD028Q28361552-0B339A20-598B-45E0-8659-B3636B3FFBCEQ30541270-771C3BA0-1617-41B3-B940-DAEF9BF7932DQ30698264-358D503E-805A-43C1-8C46-9BC66BBAAA62Q33788860-BB5FE6AF-D701-4218-9335-334448DA97BAQ33894613-9F505998-8FFA-45E4-B2F0-D2848933C23BQ33940792-B9026405-17E2-4B67-A30D-EE85AD2882B9Q33944246-36C89CA4-5EE4-43E0-8ACA-96ECCA2D73C3Q34993137-A684533E-CEFF-46CA-8D2C-8EC6F0C2C99BQ35063684-BB4EB230-1386-4D14-BF1C-8392186A0446Q35306254-C402FDB3-CAFB-4B7A-A608-1A2DD5DED0DEQ35835856-736440A4-A168-4943-A056-6C914357B7CDQ36264549-EA0D1972-61B2-4BBD-A3A0-4A935BDE663BQ36266895-CC6E27B1-D63B-4390-8F4B-9A5BD5835E20Q36315883-2A23156E-842C-41E6-9B5F-F12972067EF7Q36499746-FE038889-21BF-42E7-AD00-6515CBDA6F21Q36596961-0D2BFC54-97F7-40A2-865D-CEB53EC77070Q36654331-D74D4AE6-5929-44F2-9954-5C3B1AD3024EQ36745084-9DD4D63F-45B6-4EA7-918D-79A9B1F0557FQ36867025-B900AD86-27F6-4781-985C-6227721C2161Q36947170-AB59A2D9-59DF-4E1D-8642-F4C1C3D21E91Q37054831-6E42C8A4-E7BB-49E9-986B-4F9C8DD8E948Q37172873-F4AA84EF-9DDA-4859-9ABF-244739AE83C1Q37200841-653188FC-58B9-44F6-8E7D-4A76DA83B84BQ37211785-6FFA6B92-9AD3-41D7-9163-E75C4DFB431EQ37234759-551A825D-1A5B-408F-A548-3DB889B0431AQ37236104-1629C830-0DA5-4E08-9864-FF7F672C22E4Q37400392-C76E2A56-3BAB-4861-88B7-434708AE5D6FQ37695328-ED553055-7D03-4D75-B8BB-47812DC59614Q37722897-E74AB3DB-EA04-4320-8047-1CD6BEA62FFEQ37773480-C5C87F7F-68C2-4652-8E52-5D9877E5D835Q37853424-2E109C11-4265-4263-85D6-6C2C53C5D239Q38232734-30CC0E1B-F9C9-4FB5-8DEF-D024DDA005F8Q38239515-2B0A3CF7-1BF1-4694-914E-6F6C0F8BA339
P2860
Group I metabotropic glutamate receptors: implications for brain diseases.
description
1999 nî lūn-bûn
@nan
1999 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Group I metabotropic glutamate receptors: implications for brain diseases.
@ast
Group I metabotropic glutamate receptors: implications for brain diseases.
@en
type
label
Group I metabotropic glutamate receptors: implications for brain diseases.
@ast
Group I metabotropic glutamate receptors: implications for brain diseases.
@en
prefLabel
Group I metabotropic glutamate receptors: implications for brain diseases.
@ast
Group I metabotropic glutamate receptors: implications for brain diseases.
@en
P1476
Group I metabotropic glutamate receptors: implications for brain diseases.
@en
P2093
P356
10.1016/S0301-0082(98)00095-1
P577
1999-09-01T00:00:00Z